BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 800 shares, an increase of 100.0% from the August 31st total of 400 shares. Based on an average daily trading volume, of 57,300 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 57,300 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Trading Down 12.4%

Shares of BCTXW opened at $0.04 on Tuesday. BriaCell Therapeutics has a one year low of $0.01 and a one year high of $0.70. The company has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.06.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.